|
|
 |
|
Total Number of Holdings (excluding cash): 50
| Bristol-Myers Squibb Company |
BMY |
110122108 |
Pharmaceuticals |
25,504 |
$1,476,171.52 |
8.97% |
| Johnson & Johnson |
JNJ |
478160104 |
Pharmaceuticals |
7,681 |
$1,176,037.91 |
7.14% |
| Pfizer Inc. |
PFE |
717081103 |
Pharmaceuticals |
43,914 |
$1,095,215.16 |
6.65% |
| AbbVie Inc. |
ABBV |
00287Y109 |
Pharmaceuticals |
6,489 |
$1,088,594.64 |
6.61% |
| Merck & Co., Inc. |
MRK |
58933Y105 |
Pharmaceuticals |
10,755 |
$1,047,967.20 |
6.37% |
| Gilead Sciences, Inc. |
GILD |
375558103 |
Pharmaceuticals |
8,063 |
$714,623.69 |
4.34% |
| Viatris Inc. |
VTRS |
92556V106 |
Pharmaceuticals |
52,729 |
$692,331.77 |
4.21% |
| Cardinal Health, Inc. |
CAH |
14149Y108 |
Pharmaceuticals |
5,651 |
$680,041.34 |
4.13% |
| United Therapeutics Corporation |
UTHR |
91307C102 |
Pharmaceuticals |
1,693 |
$616,810.69 |
3.75% |
| Zoetis Inc. |
ZTS |
98978V103 |
Pharmaceuticals |
3,471 |
$609,750.57 |
3.70% |
| Jazz Pharmaceuticals Plc |
JAZZ |
G50871105 |
Pharmaceuticals |
4,661 |
$555,777.64 |
3.38% |
| Amgen Inc. |
AMGN |
031162100 |
Pharmaceuticals |
1,908 |
$549,255.96 |
3.34% |
| Eli Lilly and Company |
LLY |
532457108 |
Pharmaceuticals |
663 |
$499,510.83 |
3.03% |
| Biogen Inc. |
BIIB |
09062X103 |
Biotechnology |
3,111 |
$485,316.00 |
2.95% |
| Regeneron Pharmaceuticals, Inc. |
REGN |
75886F107 |
Biotechnology |
538 |
$399,922.30 |
2.43% |
| Charles River Laboratories International, Inc. |
CRL |
159864107 |
Biotechnology |
2,107 |
$395,905.30 |
2.41% |
| Organon & Co. |
OGN |
68622V106 |
Pharmaceuticals |
26,658 |
$392,672.34 |
2.39% |
| Elanco Animal Health Incorporated |
ELAN |
28414H103 |
Pharmaceuticals |
21,875 |
$294,000.00 |
1.79% |
| Medpace Holdings, Inc. |
MEDP |
58506Q109 |
Biotechnology |
899 |
$293,154.91 |
1.78% |
| Neurocrine Biosciences, Inc. |
NBIX |
64125C109 |
Biotechnology |
1,898 |
$234,004.42 |
1.42% |
| Exelixis, Inc. |
EXEL |
30161Q104 |
Biotechnology |
5,368 |
$186,001.20 |
1.13% |
| Alkermes Plc |
ALKS |
G01767105 |
Pharmaceuticals |
6,301 |
$175,860.91 |
1.07% |
| Halozyme Therapeutics, Inc. |
HALO |
40637H109 |
Biotechnology |
3,708 |
$169,678.08 |
1.03% |
| Perrigo Company Plc |
PRGO |
G97822103 |
Pharmaceuticals |
6,065 |
$164,664.75 |
1.00% |
| Prestige Consumer Healthcare Inc. |
PBH |
74112D101 |
Pharmaceuticals |
1,982 |
$163,851.94 |
1.00% |
| Corcept Therapeutics Incorporated |
CORT |
218352102 |
Pharmaceuticals |
2,506 |
$140,561.54 |
0.85% |
| Protagonist Therapeutics, Inc. |
PTGX |
74366E102 |
Biotechnology |
2,886 |
$117,315.90 |
0.71% |
| TG Therapeutics, Inc. |
TGTX |
88322Q108 |
Biotechnology |
3,766 |
$117,310.90 |
0.71% |
| Arcellx, Inc. |
ACLX |
03940C100 |
Biotechnology |
1,287 |
$112,252.14 |
0.68% |
| ADMA Biologics, Inc. |
ADMA |
000899104 |
Biotechnology |
5,111 |
$109,222.07 |
0.66% |
| Alnylam Pharmaceuticals, Inc. |
ALNY |
02043Q107 |
Biotechnology |
421 |
$104,740.59 |
0.64% |
| Intra-Cellular Therapies, Inc. |
ITCI |
46116X101 |
Biotechnology |
1,207 |
$103,367.48 |
0.63% |
| Vericel Corporation |
VCEL |
92346J108 |
Biotechnology |
1,713 |
$98,086.38 |
0.60% |
| Incyte Corporation |
INCY |
45337C102 |
Biotechnology |
1,347 |
$95,704.35 |
0.58% |
| ACADIA Pharmaceuticals Inc. |
ACAD |
004225108 |
Biotechnology |
5,336 |
$86,816.72 |
0.53% |
| Avidity Biosciences, Inc. |
RNA |
05370A108 |
Biotechnology |
2,011 |
$87,780.15 |
0.53% |
| Blueprint Medicines Corporation |
BPMC |
09627Y109 |
Pharmaceuticals |
926 |
$87,794.06 |
0.53% |
| Amneal Pharmaceuticals, Inc. |
AMRX |
03168L105 |
Pharmaceuticals |
10,215 |
$85,908.15 |
0.52% |
| Insmed Incorporated |
INSM |
457669307 |
Biotechnology |
1,157 |
$84,079.19 |
0.51% |
| Twist Bioscience Corporation |
TWST |
90184D100 |
Biotechnology |
2,046 |
$84,111.06 |
0.51% |
| Roivant Sciences Ltd. |
ROIV |
G76279101 |
Biotechnology |
7,233 |
$83,107.17 |
0.50% |
| Krystal Biotech, Inc. |
KRYS |
501147102 |
Biotechnology |
453 |
$80,679.30 |
0.49% |
| Kymera Therapeutics, Inc. |
KYMR |
501575104 |
Biotechnology |
1,829 |
$80,567.45 |
0.49% |
| Vertex Pharmaceuticals Incorporated |
VRTX |
92532F100 |
Pharmaceuticals |
178 |
$80,318.94 |
0.49% |
| Exact Sciences Corporation |
EXAS |
30063P105 |
Biotechnology |
1,434 |
$75,571.80 |
0.46% |
| Sarepta Therapeutics, Inc. |
SRPT |
803607100 |
Biotechnology |
652 |
$72,280.72 |
0.44% |
| Viking Therapeutics, Inc. |
VKTX |
92686J106 |
Biotechnology |
1,380 |
$71,111.40 |
0.43% |
| BioMarin Pharmaceutical Inc. |
BMRN |
09061G101 |
Pharmaceuticals |
1,089 |
$68,127.84 |
0.41% |
| Ionis Pharmaceuticals, Inc. |
IONS |
462222100 |
Pharmaceuticals |
1,855 |
$65,667.00 |
0.40% |
| US Dollar |
$USD |
|
Other |
63,423 |
$63,422.88 |
0.39% |
| Myriad Genetics, Inc. |
MYGN |
62855J104 |
Medical Services |
3,123 |
$47,781.90 |
0.29% |
Holdings are subject to change.
The holdings information set forth above for the date indicated reflects creation and redemption transactions from the prior business day and may differ from the holdings information currently available from the Fund's custodian and accounting agent. With respect to the market value of the Fund's holdings set forth above, the pricing sources are generally third party vendors. The Fund ultimately relies on pricing information provided by the Fund's accounting agent.
|
|
The information presented is not intended to constitute an investment recommendation for, or advice to, any specific person. By providing this information, First Trust is not undertaking to give advice in any fiduciary capacity within the meaning of ERISA, the Internal Revenue Code or any other regulatory framework. Financial professionals are responsible for evaluating investment risks independently and for exercising independent judgment in determining whether investments are appropriate for their clients.
|